Status Topic selection
Technology type Medicine
Decision Not selected
Reason for decision Not eligible for Health Technology Evaluation guidance
Further information Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. As is consistent with decisions made relating to other semaglutide products for treating type 2 diabetes, your product will now be routed to the NICE Centre for Guidelines where the topic will be considered as part of the ongoing update to NG28 Project information | Type 2 diabetes in adults: management (medicines update) | Guidance | NICE.
ID number 11791

Project Team

Project lead Danielle Lees

Email enquiries

For further information on how we select topics for development, please see our page about topic selection